Qyuns Therapeutics Proposes Ji Juan as Non-Executive Director

PUBT · 3d ago
Qyuns Therapeutics Proposes Ji Juan as Non-Executive Director
  • Qyuns Therapeutics shareholders will vote November 13, 2026, on revised QX001S transaction caps and Ji Juan's appointment as a non-executive director.
  • Proposed profit-sharing caps are RMB 120 million for 2026, RMB 210 million for 2027 and RMB 310 million for 2028.
  • Product-supply caps would be RMB 25 million, RMB 42 million and RMB 57 million, respectively, for transactions with Zhongmei Huadong.
  • Ji Juan's proposed annual remuneration benchmark is HKD 300,000 before tax; her term would run through the current board's tenure.
  • The independent board committee recommends voting for the revised caps; directors recommend supporting the appointment and remuneration proposal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261027-12384198), on October 27, 2026, and is solely responsible for the information contained therein.